gstar28 login register

gstar28 login register ( MENAFN - media OutReach Newswire) HONG KONG SAR - Media OutReach Newswire - 19 December 2024 - Global cybersecurity leader Trend Micro Incorporated (TYO: 4704 ; TSE: 470 ) announced its exceptional scores in the latest round of the MITRE ATT&CK® Evaluations. The results reflected Trend's position at the forefront of global threat intelligence, with its flagship platform covering all major attack steps and all sub-steps in multiple categories. To learn more about Trend's performance in the MITRE ATT&CK® Evaluations, visit: Kevin Simzer, COO at Trend: "This year's evaluations more closely mirrored real-world scenarios than in years past, which was both a challenge and an opportunity to showcase the expertise we provide to customers. Security leaders look to these evaluations to ensure that they've got the best technology and people working for them around the clock. And the results are clear: Trend Vision OneTM leaves attackers with nowhere to hide." MITRE ATT&CK® Evaluations appraise a solution's ability to detect targeted attacks leveraging known adversary behavior and recreating critical real-world attacks. This year's evaluations incorporate multiple smaller emulations for a more nuanced and targeted evaluation of defensive capabilities. Trend achieved standout results in each of the scenarios, which emulated ransomware attacks against Linux and MacOS as well as attacks from the Democratic People's Republic of Korea targeting MacOS. Coverage rates excelled across the board: MENAFN18122024003551001712ID1109009972 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Across the recent three months, 4 analysts have shared their insights on Teledyne Technologies TDY , expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 2 0 0 0 0 3M Ago 0 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $540.75, a high estimate of $585.00, and a low estimate of $500.00. Witnessing a positive shift, the current average has risen by 8.97% from the previous average price target of $496.25. Breaking Down Analyst Ratings: A Detailed Examination An in-depth analysis of recent analyst actions unveils how financial experts perceive Teledyne Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Damian Karas UBS Raises Buy $585.00 $525.00 James Ricchiuti Needham Raises Buy $550.00 $528.00 Joseph Giordano TD Cowen Raises Buy $500.00 $450.00 James Ricchiuti Needham Raises Buy $528.00 $482.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Teledyne Technologies. This information offers a snapshot of how analysts perceive the current state of the company. Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Teledyne Technologies compared to the broader market. Price Targets: Analysts predict movements in price targets, offering estimates for Teledyne Technologies's future value. Examining the current and prior targets offers insights into analysts' evolving expectations. To gain a panoramic view of Teledyne Technologies's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table. Stay up to date on Teledyne Technologies analyst ratings. Get to Know Teledyne Technologies Better Teledyne Technologies Inc sells technologies for industrial markets. Roughly a fourth of Teledyne's revenue comes from contracts with the United States government. The firm operates in four segments: instrumentation, digital imaging, aerospace and defense electronics, and engineered systems. The instrumentation segment provides monitoring instruments primarily for marine and environmental applications. The digital imaging segment contributes the largest proportion of revenue and includes image sensors and cameras for industrial, government, and medical customers. The aerospace and defense electronics segment provides electronic components and communication products for aircraft. The engineered systems segment provides solutions for defense, space, environmental, and energy applications. Understanding the Numbers: Teledyne Technologies's Finances Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position. Revenue Growth: Teledyne Technologies displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 2.92% . This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector. Net Margin: Teledyne Technologies's net margin excels beyond industry benchmarks, reaching 18.15% . This signifies efficient cost management and strong financial health. Return on Equity (ROE): Teledyne Technologies's ROE stands out, surpassing industry averages. With an impressive ROE of 2.77% , the company demonstrates effective use of equity capital and strong financial performance. Return on Assets (ROA): Teledyne Technologies's ROA excels beyond industry benchmarks, reaching 1.82% . This signifies efficient management of assets and strong financial health. Debt Management: With a below-average debt-to-equity ratio of 0.29 , Teledyne Technologies adopts a prudent financial strategy, indicating a balanced approach to debt management. The Core of Analyst Ratings: What Every Investor Should Know Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors. Breaking: Wall Street's Next Big Mover Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details . This article was generated by Benzinga's automated content engine and reviewed by an editor. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Peak XV, Bisque and Link Investment Trust will together sell a 12.2% stake, or 85.8 Lakh shares, in Awfis The investors will offload the shares at INR 680 apiece. This represents a discount of 5.2% to the stock’s closing price of INR 717.05 on Tuesday As of September 2024, Peak XV held a 10.92% stake in Awfis. Bisque and Link Investment Trust owned 14.38% and 0.36% stakes, respectively VC major Peak XV Partners, Mauritius-based investment firm Bisque Limited, and Delhi-based Link Investment Trust reportedly plan to offload Awfis shares worth INR 583 Cr. Citing sources, CNBC-TV18 reported that the three investors will together offload a 12.2% stake, or 85.8 Lakh shares, in the flexible workspace solutions company via a block deal. As per the report, the investors will offload the shares at INR 680 apiece. This represents a discount of 5.2% to the stock’s closing price of INR 717.05 on Tuesday. According to a separate NDTV Profit report, IIFL Capital Services and ICICI Securities are the book runners for the deal. As of September 2024, promoter Peak XV held a 10.92% stake in the coworking space provider, while Bisque and Link Investment Trust owned 14.38% and 0.36% stake in Awfis, respectively. Shares of Awfis are down 7.5% in the past month but up over 70% since its listing in May. Meanwhile, brokerages continue to be bullish on the company, with as many as five analysts tracking the company having a ‘BUY’ rating on the stock. The positive outlook comes largely on the back of Awfis rapidly expanding its footprint and signing new office spaces. Last month, the company announced that it would design and manage 1.65 Lakh sq ft of office space in Mumbai for the National Stock Exchange. Founded in 2015 by Amit Ramani, Awfis claims to be the largest flexible space operator in India with 181 centres, around 1.1 Lakh seats, and about 5.6 Mn square feet of chargeable area, as of March 2024. The company started operations as a coworking network, and has since expanded into the tech-enabled workspace solutions segment. It reported a consolidated net profit of INR 38.67 Cr in the second quarter (Q2) of the financial year 2024-25 (FY25). In contrast, it posted a net loss of INR 4.34 Cr in Q2 FY24. Operating revenue jumped 40.46% to INR 292.38 Cr during the quarter under review from INR 208.15 Cr in Q2 FY24. Shares of Awfis closed Tuesday (December 10) trading session 0.15% lower at INR 716.95 on the BSE.NEW ORLEANS (AP) — Darren Rizzi would be an unconventional choice to take over the New Orleans Saints' head coaching job on a permanent basis. That doesn't mean it can't happen. The Saints (4-7) had been on a seven-game skid when Rizzi, the club's special teams coordinator, was promoted. They've since won two straight, and as the club entered its Week 12 bye, prominent players were already discussing their desire to continue improving Rizzi's resume. “He’s definitely had an impact on our football team,” quarterback Derek Carr said after New Orleans' 35-14 victory over Cleveland last weekend. “We want to keep winning so that maybe he gets a chance to be the coach here for a long time. “That’s what we want as players,” Carr continued. "Hopefully, we can continue to have success, keep winning and give him that opportunity.” Before the Saints' demoralizing defeat at Carolina precipitated the firing of third-year coach Dennis Allen , Rizzi had never been a head coach at the NFL or major college level. The north New Jersey native and former Rhode Island tight end got his first head coaching job at Division II New Haven in 1999. He also coached his alma mater in 2008 before moving to the NFL with Miami in 2009 as a special teams assistant. By 2010, he was the Dolphins' special teams coordinator and added the title of associate head coach in 2017 before ex-Saints coach Sean Payton lured him to New Orleans in 2019. A common thread shared by Payton and Rizzi is that both worked under Bill Parcells. Parcells — known best for winning two Super Bowls as coach of the New York Giants — was coaching the Dallas Cowboys when Payton was his offensive coordinator. Rizzi, who grew up a Giants fan during the Parcells era, got to know his childhood idol during his first couple years in Miami, where Parcells executive vice president of football operations. Since his promotion, Rizzi has spoken to both Payton and Parcells. And he has begun to employ motivational techniques reminiscent of Payton, who left New Orleans in 2022 as the franchise leader in wins (152 in the regular season and nine in the postseason — including New Orleans' lone Super Bowl triumph). Payton as a big believer of symbolic imagery and motivational props, from baseball bats distributed before contests that were expected to be especially physical to gas cans left in the lockers of aging veterans whose performance was key to the club's success. Rizzi, who describes himself as a “blue collar” guy, has his own spin on such things. He began his tenure by asking players to accept individual responsibility for the metaphorical hole the team had dug itself and asked them all to embrace the idea of filling it up — one shovelful at a time. He even has brought a shovel — as well as a hammer, tape measure, level and other construction tools — to team meetings to help make his points. Saints tight end Taysom Hill, who also plays on special teams, has gotten to know Rizzi well during a half-decade of working together. Hill doesn't sound surprised to see Rizzi's combination of work ethic, enthusiasm and personal touch resonating across the entire team now. He also made a lot of changes , from weekly schedule adjustments to reconfiguring players' lockers by position. “He has a really good pulse on what we need collectively as a team to get ready for a football game," said Hill, who scored three touchdowns and accounted for 248 yards as a runner, receiver, passer and returner against Cleveland. “Guys have responded to that.” Because Rizzi's first victory came over the first-place Atlanta Falcons , and because the Falcons lost again last week, the Saints now trail Atlanta by just two games with six to play. Suddenly, the idea of the Saints playing meaningful football down the stretch is not so far-fetched. “We’re starting to get our swag back, and that makes me happy,” Rizzi said. ”We’re going to have some downtime now to kind of press the reset button again and see if we can make a push here." When the Saints return to action at home against the Los Angeles Rams on Dec 1, they'll do so with a level of momentum and positivity that seemed to steadily drain out of the club between their first loss of the season in Week 3 through the six straight setbacks that followed. While Saints players have tended to blame themselves for Allen's demise, they've been quick to credit Rizzi for the turnaround. “He’s pointed us and steered the ship in the right direction,” Carr said. “Hopefully, we can just keep executing at a high level for him, because we love him.” AP NFL: https://apnews.com/hub/nfl

MacKenzie Scott continues to make medical debt relief a priority in her mysterious giving. This week, Undue Medical Debt, formerly RIP Medical Debt, announced it had received a rare third gift — $50 million — from the billionaire philanthropist, signaling her satisfaction with the group’s efforts to purchase medical debt in bulk from hospitals and debt collectors. Scott has donated a total of $130 million to the organization since 2020. Medical debt is increasing despite most of the U.S. population having some form of medical insurance. Nearly 100 million people are unable to pay their medical bills, according to Third Way, a left-leaning national think tank. Overall, Americans owe about $220 billion in medical debt, with historically disadvantaged groups shouldering the bulk of the burden. Lower-income people, people with disabilities, middle-aged adults, Black people, the uninsured, and people living in rural areas are among the groups most likely to be affected by medical debt, according to the Kaiser Family Foundation. Undue Medical Debt buys debt at a discounted price, estimating that it erases about $100 in debt for each $1 donated. The group also collaborates with policymakers to encourage the adoption of measures to curb what people owe for medical care. Scott first gave Undue Medical Debt a $50 million donation in 2020, followed by a $30 million donation in 2022. With that money, the group has relieved nearly $15 billion in debt for more than 9 million people, CEO Allison Sesso said. That’s a significant leap from the $1 billion in debt relieved from 2014 to 2019, she noted. “I’m frankly astounded by this most recent gift from MacKenzie Scott and feel proud to be a steward of these funds as we continue the essential work of dismantling the yoke of medical debt that’s burdening far too many families in this country,” said Sesso. The continued funding has allowed Sesso “to not have to worry about my next dollar,” she said, and “think more strategically about the narrative around medical debt — she has helped us push that conversation.” Undue Medical Debt was started in 2014 by two former debt collection executives, Jerry Ashton and Craig Antico, who were inspired by the Occupy Wall Street movement’s advocacy for debt relief. Growth initially was slow. But with Scott’s gifts, the nonprofit has been able to staff up, produce more research, and develop relationships with policymakers who have pushed for changes to hospital billing practices to relieve debt and prevent people from accumulating it in the first place, Sesso said. Undue Medical Debt’s public policy arm has worked with lawmakers in North Carolina, which in July became the first state to offer additional Medicaid payments to hospitals that agree to adopt debt relief measures, she said. The policy change followed the publication of a 2023 report from Duke University, which found that one in five families in the state had been forced into collections proceedings because of medical debt. Since 2020, the organization’s staff has grown from three to about 40, Sesso said. Those hires included an anthropologist who collects stories from people set back by medical debt to inform the group’s research and advocacy work. Scott’s gifts also have helped improve Undue Medical Debt’s technology to identify people eligible for debt relief and to find hospitals from which it can purchase medical debt, among other things, Sesso said. “This coming year, because of this MacKenzie Scott grant, we’ll be able to add more people, making sure that we can support that growth on an ongoing basis,” Sesso said. Few repeat grantees Few organizations have received more than one gift from Scott. Other multi-grant recipients include Blue Meridian, an intermediary group that has directed billions of dollars to nonprofits around the world, and GiveDirectly, which provides no-strings-attached cash payments to low-income people globally. GiveDirectly has received $125 million from Scott since 2020. Blue Meridian has not disclosed amounts for the four gifts it’s received since 2019. Scott’s contributions to those two organizations were for specific causes like GiveDirectly’s U.S. poverty relief fund, said Christina Im, a senior research analyst at the Center for Effective Philanthropy. In the case of Undue Medical Debt, the timing of Scott’s first gifts in 2020 and 2022 seemed to correspond with COVID-relief efforts, she said. Scott, the former wife of Amazon founder Jeff Bezos, is worth an estimated $32 billion but provides few details about her grantmaking decisions. Without further information, it’s hard to know what prompted this third donation to Undue Medical Debt, but Scott has said in public statements that she wants to help those who are most in need and bear the brunt of societal ills, said Elisha Smith Arrillaga, the Center for Effective Philanthropy’s vice president for research. “I have not seen a lot of other folks funding in this area,” Smith Arrillaga added. Anger over health care costs Scott’s latest gift to Undue Medical Debt comes amid national debates about medical insurance and the cost of medical treatments. The murder of UnitedHealthcare CEO Brian Thompson on December 4 in Midtown Manhattan has heightened these conversations, with some lionizing the man who allegedly committed the crime. “That’s no way to get change, full stop,” Sesso said in reference to Thompson’s murder. “But I think the anger around insurance companies and having access to care is very clear.” The U.S. has one of the most expensive health care systems in the world. And the amount of medical debt carried by individuals seems to be increasing, noted Adam Searing, a public interest attorney and associate professor at Georgetown University, where he focuses on Medicaid and other health coverage programs. Searing previously served for 17 years as director of the Health Access Coalition at the nonprofit North Carolina Justice Center, advocating for the uninsured and underinsured. During that time, he heard from people losing their homes due to liens from hospitals. Sometimes those liens could be delayed, but it still meant that the debtors couldn’t pass those homes along to their children or grandchildren, he said. “Those stories stuck with me,” he said. “It really has an impact on families.” Relieving debt allows people to get their lives back on track and become financially secure after a major illness or series of expensive bills, Searing said. For philanthropists, it’s also a cause that is largely nonpartisan. Scott shining a spotlight on the issue is undoubtedly “a good thing,” he said. “I think it will have a big effect.” _____ Stephanie Beasley is a senior writer at the Chronicle of Philanthropy. This article was provided to The Associated Press by the Chronicle of Philanthropy as part of a partnership to cover philanthropy and nonprofits supported by the Lilly Endowment Inc. The Chronicle is solely responsible for the content. For all of AP’s philanthropy coverage, visit https://apnews.com/hub/philanthropy.MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche. Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke, with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. What to know about the stroke device The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. How it worked on the first Jackson patient Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. More about the device Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression. For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said.'Most agencies' onboarded in NSW $200m ERP rollout

Billionaire entrepreneur Elon Musk has turned his attention to the gaming industry, sharply criticising the increasing prevalence of "woke" agendas in modern video games. Musk, who is no stranger to controversy, recently took to X (formerly Twitter) to express his disdain for the trend, highlighting how games infused with progressive themes have failed to resonate with players. In a series of posts, Musk openly attacked the inclusion of pronouns in fantasy games, labelling it " utterly unacceptable ". His comments were prompted by a post from former video game executive Mark Kern, who highlighted the use of pronouns in the upcoming role-playing game Avowed . Kern described the move as symptomatic of a " woke mind virus ," urging gamers to reject such trends. Musk amplified Kern's sentiments, stating that the presence of pronouns in such games detracts from their artistic integrity. Per a video shared by Elon Docs , Musk also criticised interruptions in gaming experiences caused by what he called "DEI woke bullsh*t," referring to diversity, equity, and inclusion initiatives. Musk argued that such elements disrupt the immersive nature of video games, stating, "You do not want to do things that damage art. It breaks you out of the story." Musk's criticism comes amidst a broader cultural backlash against political messaging in video games. This sentiment has been mirrored by failures in the gaming industry, where several "woke" titles have flopped spectacularly. Among the most notable examples is Concord , an online multiplayer game developed by Sony. According to Ryan Watterson , an AI expert and filmmaker, the game's failure was due to its overtly ideological themes that alienated its target audience. Watterson observed that Concord struggled to attract players not because of gameplay issues but because its marketing and narrative clashed with gamers' values. "No one wanted to be caught dead playing or supporting it," he remarked. Similarly, other titles such as Dustborn and Suicide Squad have been criticised for prioritising political messaging over player satisfaction. The failures of games like Concord and Dustborn are emblematic of a broader miscalculation within the industry. Per reports from Mario Nawfal , host of the Largest Show on X, Concord failed to maintain even 100 concurrent players, while Dustborn peaked at a dismal 83 players. In stark contrast, Black Myth: Wukong , a non-political game, sold 10 million copies within three days of release, showcasing the significant gap between player expectations and the industry's current direction. Nawfal summarised the issue succinctly: "Gamers want content, not ideology." He argued that games steeped in political narratives often fail because they neglect the core audience—predominantly young, multicultural men—who are drawn to gameplay and storytelling rather than divisive messaging. Watterson echoed this sentiment, stating that developers are wasting massive budgets on games that cater to ideological agendas rather than consumer demand. He likened these efforts to " taking Marvel-sized money to fund Pureflix-level projects ," warning that continued failures would shrink budgets and leave room for competitors who understand market realities. The backlash against "woke" gaming may mark a turning point for the industry. Players are increasingly demanding that developers return to the fundamentals of engaging gameplay and creative storytelling. According to FandomWire , Musk's criticism has resonated with fans who are eager for games to focus on entertainment rather than activism. As failures like Concord and Dustborn continue to pile up, the gaming industry faces a critical choice: adapt to player preferences or risk further financial and reputational damage. For now, Musk's statements have amplified the call for developers to abandon divisive themes and prioritise the art of gaming itself.

ACTRESS Sharon Horgan has opened up on how "proud" she is of her family. The 54-year-old sat down with Patrick Kielty on the Late Late Show tonight to speak about her successful series Bad Sisters. The hit Apple show just released the second season last week. The darkly comedic drama has captivated audiences worldwide and is the brainchild of Emmy Award nominee and BAFTA Award-winning executive producer Sharon. The series centres around the lives of the Garvey sisters, played by a stellar cast including writer and director Sharon herself. Patrick called Sharon "the most prolific and successful writer that we have on this island" before asking her if she ever sits and realises how "successful" she is. Sharon's maternal grandparents hailed from Midfield, Mayo, but the Horgans were raised on a turkey farm in Bellewstown, Co Meath. Speaking about her upbringing, Sharon said: "I think it's sort of... well, especially if you're brought up in a turkey farm, you never really sort of expect things to work out for you in media. "But, and then for a long time, I sort of felt like I got lucky." The Irish star revealed she got her career breakthrough "well past her prime" when she co-wrote and starred in Pulling at 36-years-old. She added: "And I felt like I'd had a lot of lucky breaks. And so it wasn't really quite prepared to go, 'Ah well done me'. "But it turns out if you do it long enough and you create a few shows that are sort of bona fide hits - it just feels good. But it never stops being hard. "It's not like anything is ever just sort of handed to you just because you've made some good stuff in the past. "Everything, it's always a slog. You have to constantly hustle. I'm a hustler. "That's why I'm sort of always making stuff because I'm always hustling." Sharon's dad John Horgan passed away last December surrounded by loved ones following a brave battle with cancer. Speaking about her late dad, the award-winning writer said: "He came down on set for the first season [of Bad Sisters]. "And he came down for the second season with my mum as well and was fascinated by the process of it and how skilled everyone was at their particular part of the job and met everyone. "He was just a very curious, interested, just a great man. And very sort of... pushed us to be the best that we could be. "And even when he was in hospital, I brought him in. I did a little sort of edited clip of what we'd made so far. And I brought it in to him to show him." Sharon spoke about the "big week" for her family as her little brother Mark, who co-produced BBC podcast Where is George Gibney?, newest series titled Stakeknife came out today. While Maria, the eldest of the Horgan siblings, produced a documentary called Housewife of the Year which is was also released in cinemas today. Sharon gushed over her siblings saying: "It is a big week. I posted a thing on social media today saying, 'You wait for one Horgan project and then three of them turn up at once'. "I'm really, really proud of both of them." Sharon also has another brother, Shane, who is a former rugby union player-turned-pundit and another sister Lorraine, who followed in Sharon's footsteps as an actress and has appeared as Mrs Donovan in an episode of Peaky Blinders . RTE viewers were surprised to hear about Sharon's background and raced to social media with compliments. Lesley wrote: "You could just imagine Sharon Horgan during her brother's big rugby days ... "Watch out everyone, I'll have something massive coming soon when he's finished playing rugby." Mags said: "Wait! Sharon Horgan is of the Horgan turkey clan?!" Another fan tweeted: "Ah I'm in awe @SharonHorgan. Brilliant writing and acting #LateLateShow #BadSisters." Sharon had also dedicated a post to her siblings over on Instagram today to congratulate them. Karen said: "Wow! Incredibly talented family indeed!" Emma commented: "What on earth was sprinkled on the Horgan household, you’re all incredible!"Jamie Foxx reveals he suffered a brain bleed and a stroke, says 'I don't remember 20 days'Cal staves off Sacramento State for third straight win

WASHINGTON (AP) — The Commerce Department's efforts to curb China's and Russia's access to American-made advanced computer chips have been “inadequate” and will need more funding to stymie their ability to manufacture advanced weapons, according to a report published Wednesday by the Senate's Permanent Subcommittee on Investigations. The Biden administration imposed export controls to limit the ability of China and Russia ability to access U.S.-made chips after Russia's invasion of Ukraine nearly three years ago. The agency's Bureau of Industry and Security, according to the report, does not have the resources to enforce export controls and has been too reliant on U.S. chip makers voluntarily complying with the rules. But the push for bolstering Commerce's export control enforcement comes as the incoming Trump administration says it is looking to dramatically reduce the size and scope of federal government . President-elect Donald Trump has tapped entrepreneurs Elon Musk and Vivek Ramaswamy to lead a new “Department of Government Efficiency” to dismantle parts of the federal government. The Trump transition team did not immediately respond to a request for comment on the report. BIS’s budget, about $191 million, has remained essentially flat since 2010 when adjusted for inflation. “While BIS’ budget has been stagnant for a decade, the bureau works diligently around the clock to meet its mission and safeguard U.S. national security,” Commerce Department spokesperson Charlie Andrews said in a statement in response to the report. Andrews added that with “necessary resources from Congress” the agency would be "better equipped to address the challenges that come with our evolving national security environment.” In a letter to Commerce Secretary Gina Raimondo on Wednesday, Democratic Sen. Richard Blumenthal of Connecticut, chair of the subcommittee, pointed to an audit of Texas Instruments that showed the Russian military continued to acquire components from Texas Instruments through front companies in Hong Kong to illustrate how the export controls are failing as an effective tool. The committee's findings, Blumenthal said, suggest that Texas Instruments “missed clear warning signs” that three companies in its distribution chain had been diverting products to Russia. Texas Instruments did not immediately respond to a request for comment. “While Congress must provide BIS more resources to undertake its critical mission, it is long past time for BIS to make full use of the enforcement powers Congress has conferred upon it and take aggressive steps to cut the flow of U.S. semiconductors into the Russian war machine,” Blumenthal wrote. It's not just Texas Instruments that's the issue. The subcommittee in September published a report that found aggregated exports from four major U.S. advanced chip manufacturers nearly doubled from 2021 to 2022 to Armenia and Georgia. Both of those countries are home to front companies known to assist Russia in acquiring advanced chips made in the U.S. despite export controls. China, meanwhile, has created “vast, barely disguised smuggling networks which enable it to continue to harness U.S. technology,” the subcommittee report asserts. Washington has been gradually expanding the number of companies affected by such export controls in China, as President Joe Biden’s administration has encouraged an expansion of investments in and manufacturing of chips in the U.S. But Chinese companies have found ways to evade export controls in part because of a lack of China subject matter experts and Chinese speakers assigned to Commerce's export control enforcement. The agency's current budget limits the number of international end-use checks, or physical verification overseas of distributors or companies receiving American-made chips that are the supposed end users of products. Currently, Commerce has only 11 export control officers spread around the globe to conduct such checks. The committee made several recommendations in its report, including Congress allocating more money for hiring additional personnel to enforce export controls, imposing larger fines on companies that violate controls and requiring periodic reviews of advanced chip companies’ export control plans by outside entities. Boak reported from West Palm Beach, Florida.

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum." Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC "Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" To keep reading, please log in to your account, create a free account, or simply fill out the form below.Andrej Stojakovic made 11 free throws to help craft a team-high 20 points, freshman Jeremiah Wilkinson had his second consecutive big game off the bench and Cal ran its winning streak to three with an 83-77 nonconference victory over Sacramento State on Sunday afternoon in Berkeley, Calif. Wilkinson finished with 16 points and Rytis Petraitis 13 for the Golden Bears (5-1), whose only loss this season was at Vanderbilt. Jacob Holt went for a season-high 25 points for the Hornets (1-4), who dropped their fourth straight after a season-opening win over Cal State Maritime. Seeking a fourth straight home win, Cal led by as many as 12 points in the first half and 40-33 at halftime before Sacramento State rallied. The Hornets used a 14-5 burst out of the gate following the intermission to grab a 47-45 lead. Julian Vaughns had a 3-pointer and three-point play in the run. But Cal dominated pretty much the rest of the game, taking the lead for good on a Petraitis 3-pointer with 14:50 remaining. Stojakovic, a transfer from rival Stanford, went 11-for-15 at the foul line en route to his third 20-point game of the young season. Cal outscored Sacramento State 26-17 on free throws to more than account for the margin of victory. Coming off a 23-point explosion in his first extended action of the season, Wilkinson hit five of his 10 shots Sunday. The Golden Bears outshot the Hornets 47.2 percent to 43.1 percent. Joshua Ola-Joseph contributed 10 points and six rebounds, Mady Sissoko also had 10 points and Petraitis found time for a team-high five assists. Holt complemented his 25 points with a game-high eight rebounds. He made four 3-pointers, as did Vaughns en route to 18 points, helping Sacramento State outscore Cal 30-21 from beyond the arc. EJ Neal added 16 points for the Hornets, while Emil Skytta tied for game-high assist honors with five to go with seven points. --Field Level Media

Cal staves off Sacramento State for third straight winLate kickoff return TDs by Turpin and Thomas spark the Cowboys as they end their 5-game skidNEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it has drawn down the final tranche of €5 million (“Tranche C”) under the credit facility agreement for up to €40 million entered into with the European Investment Bank (the “EIB) on December 28, 2022 (the "Finance Contract"). With the drawdown of Tranche C, the Company has drawn down the full €40 million available under the Finance Contract. Tranche C is expected to be disbursed by the EIB by December 18, 2024. The Company plans to use the proceeds of Tranche C towards the development of its pipeline of allogeneic CAR T-cell product candidates: UCART22 and UCART20x22. As a condition to the disbursement of Tranche C the Company issued 611,426 warrants to the benefit of the EIB, in accordance with the terms of the 14 th resolution of the shareholders’ meeting held on June 28, 2024 and articles L. 228-91 and seq. of the French Commercial Code (the “Tranche C Warrants”). Each Tranche C Warrant allows the EIB to subscribe for one ordinary share of the Company, at a price of €1.70, corresponding to 99% of the volume-weighted average price of the Company’s ordinary shares over the last 3 trading days preceding the decision of the board of directors of the Company to issue the Tranche C Warrants. The total number of shares issuable upon exercise of the Tranche C Warrants represent circa 0.6% of the Company’s outstanding share capital as at their issuance date. Tranche C will mature six years from its disbursement date and will accrue interest at a rate of 6% per annum capitalized annually and payable at maturity. The other terms of the Tranche C Warrants and prepayment events of Tranche C under the Finance Contract are as set forth in the Company’s press release of April 4, 2023 and Form 6-K filed with the U.S. Securities and Exchange Commission on such date. About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes an allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to make therapeutic gene editing in hemopoietic stem cells for various diseases. As a clinical-stage biopharmaceutical company with 25 years of experience and expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN ® , its gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to treat diseases with unmet medical needs. Cellectis’ headquarters are in Paris, France, with locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more, visit our website: www.cellectis.com Follow Cellectis on social networks @cellectis on LinkedIn and X (formerly Twitter) TALEN® is a registered trademark owned by Cellectis. Cautionary Statement This press release contains “forward-looking” statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expect,” “plan,” and “will,” or the negative of these and similar expressions. These forward-looking statements, which are based on our management’s current expectations and assumptions and on information currently available to management. Forward-looking statements include statements about the date of disbursement of the Tranche C and the use of the proceeds of amounts received under the Finance Contract. These forward-looking statements are made in light of information currently available to us and are subject to numerous risks and uncertainties, including with respect to the numerous risks associated with market conditions, and our ability to satisfy the conditions precedent under the Finance Contract. Furthermore, many other important factors, including those described in our Annual Report on Form 20-F as amended and in our annual financial report (including the management report) for the year ended December 31, 2023 and subsequent filings Cellectis makes with the Securities Exchange Commission from time to time, which are available on the SEC’s website at www.sec.gov , as well as other known and unknown risks and uncertainties may adversely affect such forward-looking statements and cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Investor Relations contact: Arthur Stril, Interim Chief Financial Officer, investors@cellectis.com Attachment 20241128_Cellectis_BEI_Tranche C_ENGLISH_PR-MBT

From Wealth and Success to Murder Suspect, the Life of Luigi Mangione Took a Hard Turn

Puma Exploration Announces Closing Of $668,500 Non-Brokered Financing

YourUpdate TV Speaks with Shipt Seasonal Shopping Expert About Last-Minute Holiday Gifting and ...

Previous: gstar28 casino
Next: